Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20551152 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens
Condition: Target Drug-related Adverse Events
Interventions: Other: Urine diagnostic testing as SOC, drug regimen changes per SOC;   Other: Urine diagnostic testing with selective PGx testing, drug regimen changes based on PGx test results
2 Enrolling by invitation Patient Controlled Analgesia Pharmacogenetic Study
Condition: Pain
Intervention:

Study has passed its completion date and status has not been verified in more than two years.